Mounjaro

mounjaro.lilly.com

ownerEli Lilly and Company (USA)

originUnited States

Mounjaro is owned by Eli Lilly and Company, headquartered in the United States. Yes. The ultimate owner of Mounjaro, Eli Lilly and Company, is headquartered in the United States.

Eli Lilly and Company is a global pharmaceutical corporation headquartered in Indianapolis, Indiana, USA, specializing in the development and manufacturing of medications for various medical conditions.

Products from Mounjaro (3)

Mounjaro KwikPen · Medicine – Injectable Tirzepatide
Mounjaro TIRZEPATIDE injection · Pharmaceutical – Antidiabetic and Weight Management Medication
Mounjaro KwikPen (Tirzepatide) · Pharmaceutical – Injectable Medication (GLP-1/GIP receptor agonist)

Alternatives to Mounjaro

Teva · Teva Pharmaceutical Industries Ltd. (Israel)
STADA · STADA Arzneimittel AG (Germany)
Ibumetin · Orifarm Group A/S (Denmark)
Sandoz · Sandoz Group AG (Switzerland)
Aristo Pharma · Aristo Pharma GmbH (Germany)
Nurofen · Reckitt Benckiser Group plc (United Kingdom)

Sources: lilly.com, mounjaro.lilly.com

Check another product

disclaimer

poweredBy